1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Middle East & Africa Lung Cancer Therapy Market, by Country

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Lung Cancer Therapy Market - Key Industry Dynamics

4.1 Market Drivers:

4.1.1 Increase in Cases of Lung Cancer

4.1.2 Government Initiatives for Screening and Treatment of Lung Cancer

4.2 Market Restraints

4.2.1 High Cost of Lung Cancer Therapy

4.2.2 Lack of Awareness Regarding the Lung Cancer Therapy:

4.3 Market Opportunities

4.3.1 Rising Number of Lung Cancer Therapy in Clinical Trials

4.4 Future Trends

4.4.1 Growing Demand for Targeted Therapy

4.5 Impact Analysis:

5. Middle East & Africa Lung Cancer Therapy Market - Global Market Analysis

5.1 Middle East & Africa Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

6. Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Therapy Type

6.1 Overview

6.2 Middle East & Africa Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

6.3 Non-Invasive Therapy

6.3.1 Overview

6.3.2 Non-Invasive Therapy: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Minimally Invasive

6.4.1 Overview

6.4.2 Minimally Invasive: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

6.4.3 Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

7. Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by Indication

7.1 Overview

7.2 Middle East & Africa Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

7.3 Non-Small Cell Lung Cancer

7.3.1 Overview

7.3.2 Non-Small Cell Lung Cancer: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Small Cell Lung Cancer

7.4.1 Overview

7.4.2 Small Cell Lung Cancer: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Middle East & Africa Lung Cancer Therapy Market Revenue Share, by End User, 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Oncology Clinics

8.4.1 Overview

8.4.2 Oncology Clinics: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Research Centers

8.5.1 Overview

8.5.2 Research Centers: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Lung Cancer Therapy Market - Country Analysis

9.1 Overview

9.1.1.1 Middle East & Africa Lung Cancer Therapy Market, by Country

9.1.1.2 Saudi Arabia

9.1.1.2.1 Overview

9.1.1.2.2 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.2.3 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.2.3.1 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.2.4 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.2.5 Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.3 South Africa

9.1.1.3.1 Overview

9.1.1.3.2 South Africa: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.3.3 South Africa: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.3.3.1 South Africa: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.3.4 South Africa: Middle East & Africa Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.3.5 South Africa: Middle East & Africa Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.4 UAE

9.1.1.4.1 Overview

9.1.1.4.2 UAE: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.4.3 UAE: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.4.3.1 UAE: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.4.4 UAE: Middle East & Africa Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.4.5 UAE: Middle East & Africa Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

9.1.1.5 Rest of Middle East Africa

9.1.1.5.1 Overview

9.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

9.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type, 2020-2030 (US$ Million)

9.1.1.5.3.1 Rest of Middle East Africa: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive, 2020-2030 (US$ Million)

9.1.1.5.4 Rest of Middle East Africa: Middle East & Africa Lung Cancer Therapy Market, by Indication, 2020-2030 (US$ Million)

9.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market, by End User, 2020-2030 (US$ Million)

10. Middle East & Africa Lung Cancer Therapy Market - Industry Landscape

10.1 Overview

10.2 Growth Strategies in Middle East & Africa Lung Cancer Therapy Market

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Organic Growth Strategies

10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 RF Medical Co Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Johnson & Johnson

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Merck KGaA

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Sun Pharmaceutical Industries Ltd

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Bioventus Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Olympus Corp

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Middle East & Africa Lung Cancer Therapy Market Segmentation

Table 2. Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive- Revenue and Forecast to 2030 (US$ Million)

Table 3. Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 4. Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 5. Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 6. Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 7. South Africa: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 8. South Africa: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 9. South Africa Middle East & Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 10. South Africa: Middle East & Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. UAE: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 12. UAE: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 13. UAE: Middle East & Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 14. UAE: Middle East & Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 15. Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market, by Therapy Type - Revenue and Forecast to 2030 (US$ Million)

Table 16. Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market, by Minimally Invasive - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Middle East Africa Middle East & Africa Lung Cancer Therapy Market, by Indication - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 19. Recent Inorganic Growth Strategies in the Middle East & Africa Lung Cancer Therapy Market

Table 20. Recent Organic Growth Strategies in Middle East & Africa Lung Cancer Therapy Market

Table 21. Glossary of Terms, Middle East & Africa Lung Cancer Therapy Market

List of Figures

Figure 1. Middle East & Africa Lung Cancer Therapy Market Segmentation, By Country

Figure 2. Middle East & Africa Lung Cancer Therapy Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Middle East & Africa Lung Cancer Therapy Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Middle East & Africa Lung Cancer Therapy Market Revenue Share, by Therapy Type, 2022 & 2030 (%)

Figure 6. Non-Invasive Therapy: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Minimally Invasive: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Middle East & Africa Lung Cancer Therapy Market Revenue Share, by Indication, 2022 & 2030 (%)

Figure 9. Non-Small Cell Lung Cancer: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Small Cell Lung Cancer: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Middle East & Africa Lung Cancer Therapy Market Revenue Share, End User, 2022 & 2030 (%)

Figure 12. Hospitals: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Oncology Clinics: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Research Centers: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Others: Middle East & Africa Lung Cancer Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Middle East & Africa Lung Cancer Therapy Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 17. Middle East & Africa Lung Cancer Therapy Market, By Key Countries, 2022 and 2030 (%)

Figure 18. Saudi Arabia: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 19. South Africa: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 20. UAE: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 21. Rest of Middle East & Africa: Middle East & Africa Lung Cancer Therapy Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. Growth Strategies in Middle East & Africa Lung Cancer Therapy Market